Sort
30,917 grants matching “tumor microenvironment”
Leader cell development and function in Breast Tumor Collective Migration
$503,761Gregory Longmore · Washington University · R01 · FY2025 · CA
Role of p62 in metabolic reprograming of the tumor stroma in prostate cancer
$503,644Maria Teresa Diaz Meco Conde · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · CA
GENETICALLY ENGINEERED T CELLS FOR DIPG
$503,626Giedre Krenciute · St. Jude Children'S Research Hospital · R01 · FY2025 · NS
GENETICALLY ENGINEERED T CELLS FOR DIPG
$503,626Giedre Krenciute · St. Jude Children'S Research Hospital · R01 · FY2022 · NS
GENETICALLY ENGINEERED T CELLS FOR DIPG
$503,626Giedre Krenciute · St. Jude Children'S Research Hospital · R01 · FY2023 · NS
Th17 generation, action and therapeutic relevance in chronic lymphocytic leukemia
$503,583Nicholas Chiorazzi · Feinstein Institute For Medical Research · R01 · FY2022 · CA
Mechanisms of Tumor Derived Neutrophil Induced Apoptosis in Lymphocytes
$503,575A. McGarry Houghton · Fred Hutchinson Cancer Research Center · R01 · FY2018 · CA
Interferon regulation by NBR1-driven chaperone-mediated autophagy in stellate cells in liver cancer
$503,559Jorge Moscat · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · CA
Project 4:High Capacity Polymeric Micelle Therapeutics for Lung Cancer
$503,540Alexander V Kabanov · Univ Of North Carolina Chapel Hill · U54 · FY2016 · CA
Phosphorylation of TSC2 (S1365) as a novel Regulator of mTORC1 Signaling in T Cells
$503,539Erika L Pearce · Johns Hopkins University · R01 · FY2022 · AI
Phosphorylation of TSC2 (S1365) as a novel Regulator of mTORC1 Signaling in T Cells
$503,539Erika L Pearce · Johns Hopkins University · R01 · FY2024 · AI
Proj. 1 Targeting Tumor-Specific Neoepitopes for Glioblastoma Immunotherapy
$503,520David Reardon · Brigham And Women'S Hospital · P01 · FY2024 · CA
Tumor microenvironment: Impact on T cell tumor-targeting, activation and survival
$503,520Ronald G Blasberg · Sloan-Kettering Inst Can Research · R01 · FY2014 · CA
Novel approach to attenuate small cell lung cancer growth and metastasis
$503,488Mohd Wasim Nasser · University Of Nebraska Medical Center · R01 · FY2019 · CA
Understanding the induction of T cell dysfunction in the context of lung cancer
$503,480Stefani Spranger · Massachusetts Institute Of Technology · R37 · FY2024 · CA
Comprehensive atlas of advanced adenomas and their surrounding primed colon: A multi-omics evaluation and clinical impact assessment
$503,414William M Grady · Fred Hutchinson Cancer Center · U54 · FY2023 · CA
Prostate Microenvironmental & Prostate Cancer Progression
$503,369June Ml Chan · University Of California, San Francisco · R01 · FY2007 · CA
âPharmacologic targeting of NR4A1 and NR4A2 to activate glioblastoma treatment responseâ
$503,363Robert C Rostomily · Methodist Hospital Research Institute · R01 · FY2023 · NS
Project 1 Mouse Models Analysis
$503,335Edgar G. Engleman · Stanford University · U54 · FY2024 · CA
Protein Kinase Signaling and Cell Cycle Control
$503,262Michael B Yaffe · Massachusetts Institute Of Technology · R01 · FY2016 · ES
Protein Kinase Signaling and Cell Cycle Control
$503,262Michael B Yaffe · Massachusetts Institute Of Technology · R01 · FY2015 · ES
Protein Kinase Signaling and Cell Cycle Control
$503,262Michael B Yaffe · Massachusetts Institute Of Technology · R01 · FY2013 · ES
Protein Kinase Signaling and Cell Cycle Control
$503,262Michael B Yaffe · Massachusetts Institute Of Technology · R01 · FY2017 · ES
Immunophysiological Mechanisms in the Biological Therapy of Cancer
$503,134Robert Wiltrout · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Center for Environment-Mediated Drug Resistance in Pediatric Cancer
$503,090Yves A Declerck · Children'S Hospital Of Los Angeles · U54 · FY2011 · CA